Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors. [electronic resource]
Producer: 20050721Description: 155-66 p. digitalISSN:- 1744-7623
- Adenosine Deaminase -- physiology
- Adenosine Deaminase Inhibitors
- Afferent Pathways -- physiology
- Animals
- Appetite -- drug effects
- Diabetes Mellitus, Experimental -- drug therapy
- Diabetes Mellitus, Type 2 -- drug therapy
- Dipeptidyl Peptidase 4 -- physiology
- Drug Therapy, Combination
- Exenatide
- Glucagon -- agonists
- Glucagon-Like Peptide 1
- Glucagon-Like Peptide-1 Receptor
- Glycoproteins -- antagonists & inhibitors
- Humans
- Hypoglycemic Agents -- administration & dosage
- Hypothalamus -- drug effects
- Insulin -- biosynthesis
- Insulin Secretion
- Intestinal Mucosa -- innervation
- Islets of Langerhans -- drug effects
- Liraglutide
- Lizards
- Maleimides -- therapeutic use
- Mice
- Mice, Knockout
- Mice, Obese
- Peptide Fragments -- agonists
- Peptides -- pharmacology
- Proglucagon
- Protein Precursors -- agonists
- Rats
- Rats, Zucker
- Receptors, Glucagon -- agonists
- Venoms -- pharmacology
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.